Simplex Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.2K Sell
8,000
-600
-7% -$4.03K ﹤0.01% 6243
2026
Q1
$55.7K Buy
8,600
+8,500
+8,500% +$58.7K ﹤0.01% 5751
2025
Q4
$787 Sell
100
-6,000
-98% -$38.6K ﹤0.01% 8080
2025
Q3
$30K Buy
6,100
+100
+2% +$511 ﹤0.01% 6986
2025
Q2
$35K Hold
6,000
﹤0.01% 6271
2025
Q1
$34K Buy
+6,000
New +$41.4K ﹤0.01% 6140
2023
Q3
Sell
-100
Closed -$1K 9582
2023
Q2
$1K Buy
+100
New +$1.24K ﹤0.01% 8698
2022
Q4
Sell
-300
Closed -$1K 10159
2022
Q3
$1K Buy
+300
New +$2.02K ﹤0.01% 9609
2022
Q1
Sell
-700
Closed -$7K 11186
2021
Q4
$7K Buy
+700
New +$8.74K ﹤0.01% 9330
2021
Q2
Sell
-3
Closed -$6K 10568
2021
Q1
$6K Hold
3
﹤0.01% 8161
2020
Q4
$6K Buy
+3
New +$55 ﹤0.01% 7665

Other funds holding PROF

Simplex Trading's PROF Position: Q2 2026 in Review

Simplex Trading sold out of Profound Medical (PROF) in Q2 2026, closing a stake of 36,718 shares — an estimated $247K sold.

Simplex Trading first reported a position in PROF in Q1 2021 and held it in 12 quarters. The position peaked at $238K in Q1 2026. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Simplex Trading reported no remaining Profound Medical position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 36,718 Profound Medical shares in Q2 2026, an estimated $247K.
  • Simplex Trading first reported a position in Profound Medical in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Profound Medical position peaked at $238K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.